	Ebit		Date
Abbott	USD 2.54B	358M	2025-12
Acadia Pharmaceuticals	USD 35.76M	3.38M	2025-09
Agios Pharmaceuticals	USD -116.87M	10.19M	2025-09
Akebia Therapeutics	USD 13.51M	27.82M	2025-03
Alnylam Pharmaceuticals	USD -29.96M	34.85M	2025-09
AstraZeneca	USD 2.97B	4.48B	2025-12
BioMarin Pharmaceutical	USD -31.69M	308.58M	2025-09
Coherus Biosciences	USD -45.43M	3.19M	2025-03
Eli Lilly	USD 8.99B	1.57B	2025-12
Esperion Therapeutics	USD -16.03M	11.51M	2024-09
Halozyme Therapeutics	USD 217.92M	15.48M	2025-09
Illumina	USD 256M	6M	2025-12
Insmed	USD -261.35M	7.48M	2025-09
Ironwood Pharmaceuticals	USD 33.22M	7.58M	2024-12
J&J	USD 5.11B	2.3B	2025-12
Lexicon Pharmaceuticals	USD -49.63M	5.39M	2023-09
MacroGenics	USD 20.16M	55.51M	2025-09
MannKind	USD -41.05M	2.36M	2025-09
Merck	USD 6.24B	1.32B	2025-12
Moderna	USD -260M	557M	2025-09
Novartis	USD -9.19B	13.87B	2025-06
PTC Therapeutics	USD 3.49M	38.35M	2025-09
Puma Biotechnology	USD -2.2M	11.41M	2024-06
Sarepta Therapeutics	USD -62.88M	178.46M	2025-09
Thermo Fisher Scientific	USD 2.3B	226M	2025-12
Ultragenyx Pharmaceutical	USD -170.89M	22.68M	2025-09
United Therapeutics	USD 389.3M	112.4M	2025-09
Vanda Pharmaceuticals	USD -10.28M	721K	2024-12

Lexicon Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.